BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Aratana Therapeutics Establishes New York City Office and Announces Appointment of Executive Director of Business Development


1/6/2012 10:23:04 AM

KANSAS CITY, Kan., Jan. 6, 2012 /PRNewswire/ -- Kansas City, KS-based Aratana Therapeutics, an animal health company developing innovative medicines for companion animals, announced today that it has established a New York City office and appointed Michele A. Gallucci, MBA, as the company's executive director of business development.

The New York office, in midtown Manhattan, serves as the company's east coast base of operations. Aratana Therapeutics is headquartered in Kansas City, KS.

Ms. Gallucci, who holds a BA in Economics from the University of Massachusetts and an MBA in Finance and Health Care Management from the Wharton School at University of Pennsylvania, is based in the New York office. Prior to joining Aratana Therapeutics, Ms. Gallucci held executive-level positions in business development at Medco Health Services, Inc., the National Kidney Registry, Pfizer Inc., and Schering-Plough Corporation. She has extensive experience developing new business opportunities and executing through acquisitions, build strategies, and strategic partnerships/alliances.

"These are two important strategic moves," said CEO Dr. Linda Rhodes. "Establishing a New York office and hiring a business development professional of Michele Gallucci's caliber demonstrate the continuing growth of Aratana Therapeutics and illustrate the robust nature of our business model. Having an office convenient to the New York financial and pharmaceutical industries gives us additional access to key resources that can play significant roles in helping Aratana fulfill our promise to take human health pharmaceuticals and develop them into innovative medicines for companion animals."

About Aratana Therapeutics
Aratana Therapeutics is an animal health drug development company uniquely positioned to deliver high-quality, new medicines for unmet needs in animal health. Aratana licenses and develops proprietary, patent-protected compounds acquired from human pharmaceutical and biotechnology companies, then out-licenses to or partners with major animal health companies for commercialization. For more information, please visit www.aratanatherapeutics.com.

CONTACT: David K. Rosen, DVM
President and COO
Aratana Therapeutics, Inc.
913-951-2130
drosen@aratanarx.com

SOURCE Aratana Therapeutics



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES